Subtype
Intracranial Neoplasm
CI-CAN-00001030Explore in graph →
Non-malignant522 active trials34 evidence items
- NCIt
- C4953
Loading cancer entity…
Subtype
CI-CAN-00001030Explore in graph →
Clinical trials
2,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04908709 | Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors | recruiting | N/A | 25 | Emory UniversityOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT05124236 | Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases(PREOP-2) | recruiting | N/A | 200 | Susanne RogersOTHER | 3 | Mar 4, 2026 | clinicaltrials |
| NCT07446036 | Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery | active not recruiting | — | 500 | Beijing Tiantan HospitalOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT05397106 | Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve | active not recruiting | — | 160 | Integra LifeSciences CorporationINDUSTRY | 4 | Feb 27, 2026 | clinicaltrials |
| NCT07438860 | Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG | not yet recruiting | Phase 1 | 12 | Tiffany HodgesOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT05740839 | High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study(HYPE) | recruiting | N/A | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT05288439 | A Study of How Proton Beam Radiotherapy (PBRT) Affects Brain Function and Quality of Life in Children and Young Adults Undergoing Treatment for a Brain Tumor | active not recruiting | N/A | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT06058988 | Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer | recruiting | Phase 2 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT07301554 | Food Preferences and Craniopharyngiomas(PREFAMHYPO) | not yet recruiting | — | 346 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT07426848 | OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients(OTSMILE) | recruiting | N/A | 96 | Royal College of Surgeons, IrelandOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT07427316 | Role of Arterial Spin Labelling Magnetic Resonance Prefusion in Grading of Pediatric Brain Tumors | not yet recruiting | — | 20 | Assiut UniversityOTHER | 0 | Feb 23, 2026 | clinicaltrials |
| NCT06878469 | SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence(SIMPLIF-AI) | recruiting | N/A | 200 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07417072 | GenoDrugP 2025: Study on Three-dimensional Models Derived From Brain Tumors in Pediatric Patients | recruiting | N/A | 50 | Meyer Children's Hospital IRCCSOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07417085 | MICRO-BRAIN 2024: Study on Pediatric Brain Tumors | recruiting | N/A | 100 | Meyer Children's Hospital IRCCSOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT03970226 | Tocilizumab in Children With ACP | active not recruiting | Early Phase 1 | 9 | University of Colorado, DenverOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT04278118 | Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study(HiPPI) | recruiting | N/A | 70 | Emory UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06342908 | A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma | active not recruiting | Phase 1 | 6 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06442748 | Short Versus Long-term Levetiracetam in Brain Tumors(LIBRA) | recruiting | Phase 3 | 604 | Tata Memorial CentreOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT06132685 | Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial | recruiting | Phase 2 | 200 | Emory UniversityOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT04478279 | A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors | active not recruiting | Phase 1 / Phase 2 | 125 | Sapience TherapeuticsINDUSTRY | 2 | Feb 9, 2026 | clinicaltrials |
| NCT04706910 | 18F-DOPA II - PET Imaging Optimization | recruiting | Phase 3 | 800 | University of AlbertaOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT05890781 | Engineering Immune Organoids to Study Pediatric Cancer(IMMUNEORGANOID) | recruiting | N/A | 108 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07396896 | KETO-TUMOR: a Study on Brain Tumors and Central Obesity | recruiting | N/A | 30 | Meyer Children's Hospital IRCCSOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07398066 | DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)(DEX-NEURO) | not yet recruiting | N/A | 60 | University of MalayaOTHER | 0 | Feb 9, 2026 | clinicaltrials |
| NCT05139277 | Evaluation of the CONVIVO System | recruiting | N/A | 30 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT04459273 | Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers(FAPI PET RDRC) | active not recruiting | Phase 1 | 26 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT05700721 | Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET) | recruiting | Phase 2 | 120 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT06650163 | Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors | recruiting | Phase 1 | 20 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07389642 | Brain Oligometastasis in NSCLC(OligoLung) | active not recruiting | — | 46 | University Hospital, BordeauxOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07376473 | Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With Meningiomas(MenQOL 2) | not yet recruiting | — | 238 | Centre Hospitalier St AnneOTHER | 0 | Feb 3, 2026 | clinicaltrials |
| NCT05464992 | Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI(GlioCEST) | recruiting | N/A | 800 | Centre Paul StraussOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07381959 | Biomarkers of Brain Injury in Children With Brain Tumors(BiomarkCBT) | recruiting | — | 560 | Uppsala UniversityOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07272616 | Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison(GDW) | recruiting | — | 100 | Region StockholmOTHER_GOV | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07338526 | Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT)(IMPORT) | recruiting | N/A | 94 | Tata Memorial CentreOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT03324360 | Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial Metastasis Treated With (SRS) | recruiting | Phase 1 | 276 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT06280300 | Multi-disciplinary Care for Brain Metastases | recruiting | N/A | 40 | University of Vermont Medical CenterOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07373951 | Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis(DL-DriverBM) | enrolling by invitation | — | 380 | Ming YangOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT03526822 | Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.(MM-Predict) | recruiting | N/A | 100 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT05762419 | FUS Etoposide for DMG | recruiting | Phase 1 | 10 | Columbia UniversityOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT06208657 | Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer | recruiting | Phase 1 / Phase 2 | 90 | Australian & New Zealand Children's Haematology/Oncology GroupOTHER | 2 | Jan 28, 2026 | clinicaltrials |
| NCT05102747 | Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.(OligoBM-01) | recruiting | N/A | 504 | Centre Francois BaclesseOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT04196413 | GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG) | recruiting | Phase 1 | 97 | Stanford UniversityOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT07365410 | Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study | not yet recruiting | Phase 2 | 60 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT05556473 | F-Tryptophan PET/CT in Human Cancers | recruiting | Phase 1 | 24 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07268183 | How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors(OEMacroPrL) | recruiting | — | 180 | Hospices Civils de LyonOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours(5G-RUBY) | recruiting | Phase 1 / Phase 2 | 182 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06907485 | A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients | not yet recruiting | Phase 2 | 20 | Costas HadjipanayisOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05366881 | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease(CAMPERR) | recruiting | — | 7,000 | Adela, IncINDUSTRY | 1 | Jan 20, 2026 | clinicaltrials |
| NCT05571579 | Biological Collection of Brain Tumors(GLIOLI) | recruiting | — | 500 | Hospices Civils de LyonOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT07339085 | Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis | recruiting | N/A | 42 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 15, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Mar 4, 2026source: clinicaltrials